MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Clinical trials for MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to heal fatty liver in diabetics
Disease control Not yet recruitingThis study is testing whether a new drug called chiglitazar, when added to standard liver-protecting vitamins, can help treat a serious fatty liver disease (MASH) in people who also have type 2 diabetes. It will involve 300 adults who have both conditions. Participants will take …
Matched conditions: MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
Common body compound tested as potential liver disease treatment
Disease control Not yet recruitingThis study is testing whether betaine, a natural substance already in our bodies, can help reduce liver damage in people with MASH (a serious type of fatty liver disease). Seventy adults with MASH will take either betaine pills or placebo pills for 24 weeks while also following s…
Matched conditions: MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Southern California Institute for Research and Education • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC